Pennsylvania is seeking five more medical cannabis companies to partner with medical schools to research the potential benefits and risks of using medicinal marijuana to treat health conditions.
Last week, the state released applications for more “clinical registrants,” Pennsylvania’s term for entities that grow, process and dispense cannabis for research institutions, according to a Tribune-Review report. Applicants must have state licenses to grow and dispense cannabis, or apply for those licenses separately, the Tribune-Review reported. Applicants must also submit a contract with one of the medical schools that have been certified by the state, along with a description of the planned research that will be conducted.
Eight medical schools have been approved for the program: Penn State College of Medicine in Hershey, Drexel University College of Medicine in Philadelphia, Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, Lewis Katz School of Medicine at Temple University in Philadelphia, The Perelman School of Medicine at the University of Pennsylvania in Philadelphia, University of Pittsburgh School of Medicine in Pittsburgh, Lake Erie College of Osteopathic Medicine (LECOM) in Erie and Philadelphia College of Osteopathic Medicine in Philadelphia.
Three of these schools have secured partnerships with clinical registrants already—Drexel University College of Medicine has partnered with Agronomed Biologics LLC, Sidney Kimmel Medical College at Thomas Jefferson University has partnered with MLH Explorations LLC and Penn State College of Medicine has partnered with PA Options for Wellness.
Applications for the remaining five clinical registrant licenses are available on the Department of Health’s website. The deadline is Oct. 10.
